- Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Kezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
- Kezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care Conference
- Everest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus Nephritis
Key statistics
On Thursday, Kezar Life Sciences Inc (KZR:NSQ) closed at 0.7876, 16.75% above the 52 week low of 0.6746 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.82 |
---|---|
High | 0.8202 |
Low | 0.7849 |
Bid | 0.7737 |
Offer | 0.814 |
Previous close | 0.8166 |
Average volume | 687.47k |
---|---|
Shares outstanding | 72.80m |
Free float | 62.02m |
P/E (TTM) | -- |
Market cap | 59.45m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Apr 18 2024 21:00 BST.
More ▼